Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000905718-06-000319
Filing Date
2006-10-19
Accepted
2006-10-19 15:59:07
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC13G repligen13gaug06.txt SC 13G 11764
  Complete submission text file 0000905718-06-000319.txt   13728
Mailing Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453
Business Address 41 SEYON STREET BUILDING 1, SUITE 100 WALTHAM MA 02453 7814499560
REPLIGEN CORP (Subject) CIK: 0000730272 (see all company filings)

EIN.: 042729386 | State of Incorp.: DE | Fiscal Year End: 0331
Type: SC 13G | Act: 34 | File No.: 005-38071 | Film No.: 061153469
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 301 TRESSER BOULEVARD SUITE 1320 STAMFORD CT 06901
Business Address 301 TRESSER BOULEVARD SUITE 1320 STAMFORD CT 06901 203-653-2500
Xmark Opportunity Partners, LLC (Filed by) CIK: 0001347039 (see all company filings)

EIN.: 202052197 | State of Incorp.: DE
Type: SC 13G